Drug-induced liver injury: Is it somehow foreseeable?

被引:138
作者
Tarantino, Giovanni [1 ]
Di Minno, Matteo Nicola Dario [1 ]
Capone, Domenico [2 ]
机构
[1] Univ Naples Federico II, Med Sch Naples, Sect Hepatol Internal Med, Dept Clin & Expt Med, I-80131 Naples, Italy
[2] Univ Naples Federico II, Med Sch Naples, Clin Pharmacol Unit, Dept Neurosci, I-80131 Naples, Italy
关键词
Drug-induced liver injury; Cytochrome P-450; Drug metabolism; Pharmacogenomics; Herbal remedies; INDUCED GRANULOMATOUS HEPATITIS; MITOCHONDRIAL PERMEABILITY TRANSITION; INDUCED CHOLESTATIC HEPATITIS; OF-THE-LITERATURE; INDUCED HEPATOTOXICITY; INTRAHEPATIC CHOLESTASIS; VENOOCCLUSIVE DISEASE; METABOLIZING-ENZYMES; CAUSALITY ASSESSMENT; ACETAMINOPHEN HEPATOTOXICITY;
D O I
10.3748/wjg.15.2817
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
The classic view on the pathogenesis of drug-induced liver injury is that the so-called parent compounds are made hepatotoxic by metabolism (formation of neosubstances that react abnormally), mainly by cytochromes P-450 (CYP), with further pathways, such as mitochondrial dysfunction and apoptosis, also playing a role. Risk factors for drug-induced liver injury include concomitant hepatic diseases, age and genetic polymorphisms of CYP. However, some susceptibility can today be predicted before drug administration, working on the common substrate, by phenotyping and genotyping studies and by taking in consideration patients' health status. Physicians should always think of this adverse effect in the absence of other clear hepatic disease. Ethical and legal problems towards operators in the health care system are always matters to consider. (C) 2009 The WJG Press and Baishideng. All rights reserved.
引用
收藏
页码:2817 / 2833
页数:17
相关论文
共 204 条
[1]
Ahn Byung-Min, 2004, Korean J Gastroenterol, V44, P113
[2]
The natural history of histologically proved drug induced liver disease [J].
Aithal, PG ;
Day, CP .
GUT, 1999, 44 (05) :731-735
[3]
INTRAHEPATIC CHOLESTASIS INDUCED BY AMOXICILLIN CLAVULANIC ACID (AUGMENTIN) - A REPORT ON 2 CASES [J].
ALEXANDER, P ;
ROSKAMS, T ;
VANSTEENBERGEN, W ;
PEETERMANS, W ;
DESMET, V ;
YAP, SH .
ACTA CLINICA BELGICA, 1991, 46 (05) :327-332
[4]
ALLOPURINOL HEPATOTOXICITY - REPORT OF 2 CASES AND REVIEW OF THE LITERATURE [J].
ALKAWAS, FH ;
SEEFF, LB ;
BERENDSON, RA ;
ZIMMERMAN, HJ ;
ISHAK, KG .
ANNALS OF INTERNAL MEDICINE, 1981, 95 (05) :588-590
[5]
Phenytoin-induced toxic cholestatic hepatitis in a patient with skin lesions:: Case report [J].
Altuntas, Y ;
Öztürk, B ;
Erdem, L ;
Günes, G ;
Karul, S ;
Uçak, S ;
Sengül, A .
SOUTHERN MEDICAL JOURNAL, 2003, 96 (02) :201-203
[6]
Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis [J].
Anania, FA ;
Rabin, L .
AMERICAN JOURNAL OF MEDICINE, 2002, 112 (09) :741-742
[7]
Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].
Andrade, RJ ;
Lucena, MI ;
Fernández, MC ;
Pelaez, G ;
Pachkoria, K ;
García-Ruiz, E ;
García-Munoz, B ;
González-Grande, R ;
Pizarro, A ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Romero-Gomez, M ;
Navarro, JM ;
Planas, R ;
Costa, J ;
Borras, A ;
Soler, A ;
Salmerón, J ;
Martin-Vivaldi, R .
GASTROENTEROLOGY, 2005, 129 (02) :512-521
[8]
HISTOPATHOLOGIC FINDINGS IN THE LIVER OF RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH LONG-TERM BOLUS METHOTREXATE [J].
APONTE, J ;
PETRELLI, M .
ARTHRITIS AND RHEUMATISM, 1988, 31 (12) :1457-1464
[9]
Agreement of expert judgment in causality assessment of adverse drug reactions [J].
Arimone, Y ;
Bégaud, B ;
Miremont-Salamé, G ;
Fourrier-Réglat, A ;
Moore, N ;
Molimard, M ;
Haramburu, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (03) :169-173
[10]
MORPHOLOGIC ALTERATIONS IN PATIENTS WITH ALPHA-METHYLDOPA-INDUCED LIVER-DAMAGE AFTER SHORT-TERM AND LONG-TERM EXPOSURE [J].
ARRANTO, AJ ;
SOTANIEMI, EA .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1981, 16 (07) :853-863